Scientific and educational activities

58th General Assembly of ERIC Members at the EHA Congress 2025

Date and location: June 12, 2025, Milan

Agenda:

  • Clinical Significance and Treatment Outcomes of Accelerated Chronic Lymphocytic Leukemias
  • Effectiveness and safety of I+V treatment in patients with CLL
  • TP53 database project
  • Clinico-biological characteristics of patients diagnosed with young-onset chronic lymphocytic leukemia
  • Treatment patterns and outcomes in patients with CLL aged 80 years or older

Further information: https://ericll.org/eha2025/

WP7 CLL/ERIC Meeting at ELN Symposium 2025

Date and location: February 25, 2025, Mannheim

Agenda:

  • Project update: RESOLVE trial
  • Accelerated CLL
  • Complex karyotype in the era of targeted therapies

Further information: https://ericll.org/eln-2025/

ERIC International Preceptorship

Date and location: 10-11 April 2025, Bucharest

ELN Breakfast Meeting at ASH 2025

Date and location: 7 December 2025, Orlando, USA

Agenda:

  • Characteristics and outcome of CLL progression during (con-DR) or after con-PD) concurrent BTKi/BCL2i
  • Complex karyotype in the era of novel agents
  • Outcomes of ven-based regimens after BTKi discontinuation

Further information: https://ericll.org/meetings/ash-2025/